Utrecht-based Gilde Healthcare, a specialised healthcare investor, announced on Wednesday that it has launched a new investment fund called Gilde Healthcare Venture&Growth VI.
The new fund has received €600M in commitments and is focused on investing in fast-growing companies developing solutions for better care at a lower cost.
Focus on Europe and North America
The company says the fund will primarily invest in companies in Europe and North America that are active in the digital healthcare, medical technology (MedTech), and therapeutics sectors.
The VC’s latest fund is backed by a balanced mix of international investors, including corporates, banks, pension funds, insurers, fund-of-funds, sovereign wealth funds, endowments, family offices, entrepreneurs, and the Gilde team.
The company also says the new fund will invest €10-60M per new portfolio company.
Together with the last Venture&Growth fund (closed in 2020) and Gilde Healthcare Private Equity IV (closed in 2022), Gilde Healthcare has raised €1.5B in capital over the last three years.
Pieter van der Meer, Managing Partner at Gilde Healthcare, says, “We are pleased with the strong interest from investors who support our mission. Innovations that improve the quality of care but also keep it affordable are essential to ensure access to healthcare. Our broad strategy, covering digital health, MedTech, and therapeutics, results in a holistic approach allowing us to select the most optimal and cost-effective solution for the individual patient. With a team of sector experts, we help companies to further scale medical innovations and to make them accessible globally.”
Gilde Healthcare: What you need to know
Gilde Healthcare is a specialised healthcare investor managing over €2.5B across two fund strategies – Venture&Growth and Private Equity.
The Venture&Growth fund of Gilde Healthcare invests in fast-growing companies active in digital health, medtech, and therapeutics, based in Europe and North America.
The Private Equity fund of Gilde Healthcare participates in profitable lower mid-market healthcare companies based in North-Western Europe.
01
Meet the 11 social innovators pitching at DNNL X Social Enterprise NL Launchpad Demo Day 2024